Richard Pietras, M.D., Ph.D.

University of California, Los Angeles
email: rpietras@ucla.edu

Grants

Metformins in Triple-Negative Breast Cancer Immunotherapy 2018 (Cycle 24)
IDEA (Innovative, Developmental, and Exploratory Awards) 24IB-0058 $187,358
New Estrogen Receptor Downregulators for Breast Cancer 2010 (Cycle 16)
IDEA (Innovative, Developmental, and Exploratory Awards) 16IB-0042 $150,000
Membrane-associated Estrogen Receptors in Breast Cancer 2009 (Cycle 15)
IDEA (Innovative, Developmental, and Exploratory Awards) 15IB-0058 $149,119
New Radiation Therapy for HER-2-overexpressing Breast Cancer 1999 (Cycle V)
IDEAS II 5JB-0105 $200,000
New Endocrine Strategy to Prevent Breast Cancer Progression 1995 (Cycle I)
Research Project Awards 1RB-0297 $263,080


Biologic Roles of Estrogen Receptor-b and Insulin-Like Growth Factor-2 in Triple-Negative Breast Cancer doi:10.1155/2015/925703
  Periodical: BioMed Research International
  Author(s): Nalo Hamilton, Diana Márquez-Garbán, Vei Mah, Gowry Fernando, Yahya Elshimali, et al.
  Yr: 2015 Vol: 2015 Nbr: 925703 Pgs: 15 pages
  Associated Grant: New Estrogen Receptor Downregulators for Breast Cancer
 
Extranuclear Estrogen Receptors in Breast Cancer.
  Periodical: Cancer Research
  Author(s): Márquez-Garbán DC, Chen HW, Goodglick L, Fishbein MC, Pietras RJ
  Yr: 2010 Vol: 70 Nbr: 24 (suppl) Pgs:
  Associated Grant: Membrane-associated Estrogen Receptors in Breast Cancer
 
Steroid hormone receptors in target cell membranes
  Periodical: Endocrine
  Author(s): Pietras RJ, Nemere I, Szego CM
  Yr: 2001 Vol: 14 Nbr: Pgs: 417-427
  Associated Grant: New Radiation Therapy for HER-2-overexpressing Breast Cancer
 
Epidermal growth factor receptor and tyrosine phosphorylation of estrogen receptor
  Periodical: Endocrine
  Author(s): Marquez DC, Lee J, Lin T, and Pietras RJ
  Yr: 2001 Vol: 16 Nbr: 2 Pgs: 73-81
  Associated Grant: New Radiation Therapy for HER-2-overexpressing Breast Cancer
 
Oncogene activation and breast cancer progression
  Periodical: Contemporary Endocrinology
  Author(s): Pietras RF, Pegram MD
  Yr: 1999 Vol: 11 Nbr: Pgs: 133-154
  Associated Grant: New Endocrine Strategy to Prevent Breast Cancer Progression
 
Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells.
  Periodical: Oncogene
  Author(s): Aguilar Z, Akita RW, Finn RS, Ramos BL, Pegram MD, Kabbinavar FF, Pietras RJ, et al.
  Yr: 1999 Vol: 18 Nbr: 44 Pgs: 6050-62
  Associated Grant: New Endocrine Strategy to Prevent Breast Cancer Progression
 
Antitumor effect of phosphotyrosyl-peptides that block binding of estrogen receptor to DNA in human breast cancer cells
  Periodical: Proceedings of the American Association for Cancer Research
  Author(s): Pietras RJ, Lee J
  Yr: 1997 Vol: 38 Nbr: Pgs: 174
  Associated Grant: New Endocrine Strategy to Prevent Breast Cancer Progression
 
HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormore-independent growth in human breast cancer cells.
  Periodical: Oncogene
  Author(s): Pietras RJ, Arboleda D, Reese N, Wongvipat M, et al.
  Yr: 1995 Vol: 10 Nbr: Pgs: 2435-2446
  Associated Grant: New Endocrine Strategy to Prevent Breast Cancer Progression